Review
Open access
Jul 2026
Neoadjuvant Chemotherapy Followed by Interval Debulking for Advanced-Stage Endometrial Cancer: Survival Outcome Based on Surgical and Molecular Characteristics
Most patients experienced tumor shrinkage after chemotherapy, and more than 80% had no visible tumor remaining after surgery, adding to the growing evidence supporting neoadjuvant chemotherapy as a treatment option for selected patients with advanced endometrial cancer.
Mira Kheil, Tariq Mekkaoui, Emily Andresan et al.
· Current Oncology · 0 citations